Skip to main content
Clinical Trials/NCT05920486
NCT05920486
Recruiting
Not Applicable

The Effectiveness of High-Intensity Laser Therapy in Reducing Pain and Improving Function in Patients With Sacroiliitis: A Sham-Controlled Randomized Trial

Ahram Canadian University1 site in 1 country64 target enrollmentJune 22, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sacroiliac Arthritis
Sponsor
Ahram Canadian University
Enrollment
64
Locations
1
Primary Endpoint
Changes in Pain intensity
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

To investigate the effectiveness of High-Intensity Laser Therapy (HILT) in reducing pain and improving function in patients with sacroiliitis, aged 40-60 years.

Registry
clinicaltrials.gov
Start Date
June 22, 2023
End Date
April 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Magdy ElMeligie

Lecturer of Physical Therapy and Director of Electromyography Lab

Ahram Canadian University

Eligibility Criteria

Inclusion Criteria

  • Age: Adults aged 40-60 years old
  • Diagnosis: Confirmed diagnosis of sacroiliitis by a specialist (e.g., rheumatologist, orthopedic surgeon, or radiologist) based on a combination of clinical findings, laboratory tests, and imaging studies
  • Clinical findings: Presence of at least one or more of the following clinical signs and symptoms suggestive of sacroiliitis:
  • Low back pain, buttock pain, or hip pain, worsened by prolonged sitting, standing, or walking
  • Stiffness in the lower back, buttock, or hip region, particularly in the morning or following prolonged inactivity
  • Pain improvement with physical activity or exercise
  • Duration of symptoms: Experiencing symptoms for at least 3 months

Exclusion Criteria

  • Previous surgery or invasive procedures targeting the sacroiliac joints
  • Contraindications to physical interventions (e.g., spinal instability, fractures, or severe neurological deficits)
  • Presence of other spinal pathologies or systemic inflammatory conditions that could confound the assessment of sacroiliitis (e.g., lumbar disc herniation, ankylosing spondylitis, or rheumatoid arthritis)
  • Pregnant or breastfeeding women

Outcomes

Primary Outcomes

Changes in Pain intensity

Time Frame: Changes in Pain intensity Measured at baseline, week 4, week 8 (end of treatment), and week 12 (follow-up)

The Numeric Pain Rating Scale is a self-reported measure of pain intensity, with a score ranging from 0 (no pain) to 10 (worst pain imaginable). Participants will be asked to rate their pain intensity at rest and during movement of the sacroiliac joint.

Changes in Functional ability

Time Frame: Changes in Functional ability Measured at baseline, week 4, week 8 (end of treatment), and week 12 (follow-up)

The Oswestry Disability Index is a self-reported measure of functional ability, with a score ranging from 0% (no disability) to 100% (maximum disability). Participants will be asked to complete a questionnaire assessing their ability to perform various activities of daily living, such as walking, sitting, and standing.

Secondary Outcomes

  • Changes in Range of Motion in the Lumbopelvic Region (Modified Schober Test and Hip Flexion/Extension)(Changes in Range of Motion Measured at baseline, week 4, week 8 (end of treatment), and week 12 (follow-up))
  • Changes in Health-Related Quality of Life (Short Form 36 Health Survey)(Changes in Health-Related Quality of Life Measured at baseline, week 4, week 8 (end of treatment), and week 12 (follow-up))
  • Global Perceived Effect (Global Perceived Effect Scale)(Measured at week 8 and week 12 (follow-up))

Study Sites (1)

Loading locations...

Similar Trials